Vol. 47, No. 5, 1972
BIOCHEMICAL
A NON-FUNCTIONAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ARGININE
BIOSYNTHETIC
IN POLYOMA INFECTED-MOUSE
Division Department
Received
April
EMBRYO CELLS
R. A. Consigli,'
A. L. Winters,'
PATHWAY
and Q. R. Rogers
of Biology, Subdivision of Molecular Biology and Genetics Kansas State University, Manhattan, Kansas and of Physiological Sciences, School of Veterinary Medicine University of California, Davis, California
24, 1972
The normal pathway for the biosynthesis of arginine was non-functional in polyoma infected-mouse cells. During viral replication, equimolar concentration of citrulline substituted for arginine but equimolar or ten times equimolar concentration of ornithine did not replace arginine. Purified polyoma virus obtained from infected cultures that were allowed to incorporate citrulline-14C revealed upon amino acid analysis that the label was found exclusively as arginine-14C. When the experiment was repeated using ornithine-14C the label was found as proline-14C and glutamate-14C and not arginine. Both normal and polyoma infected-mouse embryo cells possessed an active ornithine carbamoyltransferase. The inability of ornithine to serve as an arginine precursor appears to be due to the fact that exogenous ornithine is utilized by ornithine-&transaminase to synthesize proline and glutamate and not by ornithine carbamoyltransferase to synthesize citrulline. Successful virus
(5),
medium. the
infection
SV40 (6) It
has been
inhibition
the reason(s) cultures 1
2
of tissue
and polyoma
virus
suggested
(5,7,8)
of an arginine-rich for
have not
cultures
th$ strict
(7)
by herpes requires
that
arginine
been demonstrated.
Thus,
adeno-
in the maintenance
deprivation
protein
requirement
(l-4),
arginine
arginine
structural
virus
effected
of the virus.
of virus
infected
an investigation
However, tissue
of arginine
Recipient of an NIH Predoctoral Fellowship: 5-Fl-GM-30,342. address is: Department of Microbiology, School of Medicine, Pennsylvania, Philadelphia, Pennsylvania.
His present University of
Recipient of USPHS Career Development Award: ported by a grant from the USPHS: CAo7139.
work
Copyright01972,by
Academic Press,Inc.
1044
CA12056.
This
was sup-
BIOCHEMICAL
Vol. 47, No. 5, 1972
biosynthesis to gain
in polyoma
a fuller
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
virus-infected
understanding
mouse embryo
of the
arginine
MATERIALS Primary
mouse embryo cell
(MEM) medium
containing
penicillin,
200 units/ml;
Experiments
were
adsorption
of virus
in Eagle's
medium
on occasion
virus
cultures
that
1 pc/ml
medium
used for
were
(sp.
was purified
virus
from
with
6N HCl (nitrogen
HCl,
the sample
using
a three
amino
acids
column cell
meter
Ornithine
by suspending
acid
standard
with
the harvested the cells
cells
for
After
days. (9).
removal
The
of the
acid
analyzer
exchange
anthracene.
spectrometer
which
meter
recorder, for
The
was
recorder thus
was set
facilitating
quantitation
of
14 C and arginine-
citrulline2.1.3.3)
Cell
activity free
in Tris-acetate
in a Sorvall
five
was hydrolyzed
the ion
crystalline
cultures.
or
of individual
from
The factor
with
Schwarz/Mann)
120 B amino
effluent
(OTC; EC No. infected
calf
infected
supplemented
gradient
19 hr.
The rate
peak.
from
Radioactivity
analyzer
After
fetal
described
density
Beckman
scintillation
using
and polyoma
and homogenizing
for
the
packed
carbamoyltransferase in normal
chloride
and recorder.
as the amino
was determined
as previously
system.
of each radioactive
radioactivity
10 nmoles)
in a Packard
medium
SchwarzfMann)
by passing
mg/ml.
maintained
5% dialyzed
5 mcfmmole,
at 121'
cell
were
8 mcfmmole,
buffer
a 2.0 ml flow
cultures
act.
cesium
0.01
confluent.
was purified
Eagle's
in a modified
gradient
to a rate
identification
prepared
second
was determined
to the same speed
determined
the
antibiotics:
or ornithine.
analysis
C (sp.
with
appeared
containing
and quantitated
was analyzed
was monitored
connected
act.
atmosphere)
step
through
acid
14
the
citrulline,
in Eagle's
and kanamycin,
cultures 3 hr,
in complete
of DL-ornithine-5
virus
purified
with
maintained
L-citrulline-ureido-14C Polyoma
the
arginine)
amino
and maintained
0.2 mg/ml;
for
or without
grown
serum and supplemented
(100 p.f.u./cell)
serum supplemented Polyoma
calf
72 hr after
(with
requirement.
were
streptomycin,
initiated
was performed
AND METHODS
cultures
5% fetal
cultures
Omnimixer
was lysates
buffer for
14 C.
were
(pH 8.0, 0.5 min
Vol. 47, No. 5,1972
BIOCHEMICAL
at maximum rheostat
setting.
and the supernatant
assayed
taining
1.0 ml of lysate;
0.1 Pmoles
The homogenate for
of cold
citrulline
was centrifuged
OTC activity.
25 pmoles
MgC12 was incubated
by addition
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
TCA (5% final)
The 2.0 ml assay
L-ornithine;
at 37"
1500 x g for
for
15 pmoles
60 min.
carbamyl
The reaction
and the supernatant
mixture
fluid
10 min con-
phosphate;
was terminated assayed
for
(10). RESULTS AND DISCUSSION
In viral for
arginine
replication whereas
equimolar equimolar
ornithine
did
not
ornithine
are
constituents
interest
to allow
replace
concentration
or
ten times
arginine
(Fig.
equimolar
1).
in the arginine
infected
5.d
cells
to separately
20 HOURS
Since
I
substituted
concentrations both
biosynthetic
I 0
of citrulline
incorporate
citrulline pathway, citrulline-
I
40
60
AFTER
INFECTION
Fig. 1. Growth of polyoma virus in Eagle's medium. M, complete medium; H, medium without arginine; O------O, medium with 0.6 mM L-citrulline substituted for arginine; @------ @, medium with 0.6 mM or 6.0 mM L-ornithine substituted for arginine. 1046
of and it
was of 14 C
Vol. 47, No. 5, 1972
BIOCHEMICAL
and ornithine-14C if
the label
acid
was ultimately
analysis Table
Amino
and to analyze
of these 1.
the purified
acid
acid
viral
analysisa
Moles
preparations of purified
acid
progeny
to determine
arginine.
revealed polyoma
per 100 Moles
range aspartic
polyoma
as 14 C labeled
incorporated
purified
Amino
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
that
Amino radioactive
virus. % total
radioactivity
average
8.4-10.9
10.0
threonine
9.5-10.4
9.9
serine
5.2-8.3
6.5
7.7-9.6
8.7
7.1C
proline
8.5-10.6
9.6
74.4c
glycine
7.9-10.9
9.3
alanine
2.6-5.1
4.1
valine
8.9-9.2
9.0
glutamic
acid
cystine
trace
methionine
trace
isoleucine
4.3-4.9
4.7
leucine
8.6-9.4
8.9
tyrosine
trace
phenylalanine
2.2-2.8
2.4
lysine
8.5-10.4
9.7
histidine
1.5-2.9
2.1
ammonia
not
arginine
4.7-5.7
tryptophan
not
a
average
b virus
of three was grown
c;;~;;e;;ofrYP determined.
amino
calculated 5.1
100b
determined
acid
analyses
in L-citrulline-ureido-
14 C labeled
medium
in DL-ornithine-5-14C labeled medftm. The lack of 100% C input counts was probably due to CO2 which was not 1047
Vol. 47, No. 5, 1972
incorporation
from
exclusively amino
with
acid
analyses
obtained
and Kass
(12),
tyrosine
content
this
14 C label
the
(74.4%) did
not
were except
14 C labeled
was not
acid
any unusual
similar
1).
low
preparation
arginine,
but
The amino
acids.
acid
In general,
by Murikami
tyrosine
of the polyoma
associated
However,
viral
with
reported
the consistently
may be characteristic
(Table
(7.1%). amino
to analyses
was found
purified
associated
and glutamic
reveal
for
cultures
peak of the analysis
of the ornithine-
proline virus
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
14 C labeled
citrulline-
the arginine
that
with
of polyoma
the
analysis
demonstrated marily
BIOCHEMICAL
analysis the
et al.,
content. virus
pri-
(11)
The low
strain
used
in
investigation. The above data
catalyzes
the
may be lacking pqlyoma
(Fig.
synthesis
1, Table
1) raised
of citrulline
in the polyoma
infected-mouse
from
the possibility ornithine
infected-mouse
embryo cells
were
OTC which
and carbamyl
embryo cells. then
that
assayed
for
phosphate
Normal OTC activity
20.0
i
IS.0\f “0 c 10.0z= z3 E 5.0 i 2
(1
S
I2 HOURS
I5
IO AFTER
21
24
30
0.0
INFECTION
Fig. 2. Ornithine carbamoyltransferase in normal and polyoma infected-mouse O----O infected; M normal; p.f.u.
1048
27
activity embryo cells. and O------O
and over
BIOCHEMICAL
Vol. 47, No. 5, 1972
a 30 hr multiplication infected
cycle.
cells
possessed
enzyme activity
observed
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
It was found
OTC activity
that
both
2).
The three-fold
(Fig.
9 hr post
infection
normal
and polyoma increase
can not be explained
in
at this
time. The reason
for
the failure
to be at the intracellular OTC appeared thesize acid
via
but
ornithine
that
of arginine
infectious
progeny
non-functional required
arginine
it
is
pathway
phosphate
into
one for
Apparently,
of ornithine total
since
suppression
might
result
phosphate
arginine
of
in a synthetase
biosynthesis.
in eucaryotic
pyrimidine
14).
cells
This
that
two carbamyl
biosynthesis
and one for
the arginine
biosynthetic
(15 - 21).
concluded
from
the data
is non-functional a stringent
of carbamyl
was demonstrated
existed,
biosynthesis
It
ducing
carbamyl
source
which
and glutamic
and endogenous
(13,
medium produced
may be due to a lack
since
synthetases
biosynthesis
possibility
to syn-
was demonstrated
ornithine
an intracellular
An alternate
(7).
channeling
may be a reality
lack
It
exogenous
arginine
from maintenance
pathway
for
phosphate
cells
pathway.
proline
appears enzyme
was not used
to synthesize
handled
system
The initial
ornithine
(OTA)
to OTC for
in this
level.
was utilized
the OTA pathway
infected-mouse
the removal
exogenous
6 transaminase
was channeled
arginine
(ornithine)
since instead
the ornithine
in Neurospora
polyoma
substrate
non-functional
citrulline
to synthesize
presented
in polyoma
requirement
for
that
infected-mouse exogenous
embryo
cells,
thus
pro-
arginine.
References 1.
Tankersley,.R.
W.
J.
Bacterial.,
2.
Becker,
Y.,
3.
Inglis,
V. B.
J. gen.
4.
Spring,
S. B.,
Roizman,
5.
Rouse,
6.
Goldblum,
7.
Winters,
Olshevsky,
H. C., N., A. L.,
U., Virol.
Z.,
609 (1964).
and Levitt, 2,
R. W.
and Becker,
and Consigli,
J.
J.
gen.
Virol.
1, 471
(1967).
9 (1968).
B. and Spear,
and Schlesinger, Ravid,
87,
R. A.
1 l-IA4
P. G.
Virology
Virology
2,
Y.
J. gen.
J. gen.
Virol.
3,
710 (1969).
513 (1967). Virol. lo,
3,
143 (1968).
53 (1971).
BIOCHEMICAL
Vol. 47, No. 5, 1972
8.
Russell,
W. C.,
and Becker,
9.
Consigli, R. A., (1966). S. B.,
Y.
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Virology
35,
Minocha,
H. C.,
and Abo-Ahmed,
and Cohen,
P. 0.
J. Biol.
10.
Koritz,
11.
Murakami, Mol.
12.
Kass,
13.
Davis,
R. H.
J. Bacterial.
14.
Davis,
R. H.,
and Mora,
15.
Lacroute, 3,
F., Pierard, 127 (1965).
16.
Hirsch,
M. L.
17.
Lan,
18.
Nakanishi, S., Ito, 33, 774 (1968).
19.
Hager,
20.
Williams,
L. G.,
21.
Williams, 973
L. G., (1971).
W. F., Fine, R., Harrington, Biol. x, 153 (1968).
S. J.
S. J.,
J. Virol.
96, J.
A.,
and Jones,
J. Bacterial.
Chem. 209, M. R.,
92,
789
145 (1954).
and Ben Sassen,
Z.
J.
389 (1968).
J. Bacterial. Grenson, Sci.
H. J., K.,
H.
381 (1970).
C. R. Acad.
Sallach,
S. E.,
2,
18 (1968).
M.,
(Paris)
and Cohen,
and Tatibana, M. E.
96,
and Wiame, 267, P. P.
M.,
J. Biol.
1473
J. M.
Biochemistry Biophys.
Chem. 242,
5674
R. H.
J.
Bacterial.
Bernhardt,
S. A.,
and Davis,
J. gen.
Microbial.
(1968).
Biochem.
and Davis,
1050
383 (1968).
103, R. H.
8,
3673
Res.
(1969).
Commun.
(1967).
335 (1970). J. Biol.
Chem. 246,